Abstract
Why do some populations display a higher attack and mortality rate from the current coronavirus disease 2019 (COVID-19) pandemic than others? Are there geographic, environmental, behavioral, genetic, and comorbidity differences that influence spatial dynamics of COVID-19 transmission and outcomes? Where are the regional and country-level hotspots, and what drives those hotspots? These are some of the questions the current chapter strives to answer. The dynamics of transmission and consequences of COVID-19 are not homogeneous but instead have a geographical and spatial clustering. Population-level genetic, vaccination rates, health care disparities, SARS-CoV-2 variants, and meteorological factors are all underlying determinants of the disease dynamics globally, regionally, nationally, and locally. Disease surveillance frameworks to control, mitigate, and prevent the SARS- CoV-2 infections, particularly in low- and middle-income countries, are critical. Lastly, we highlight the spatial differences in the consequences of the pandemic focusing on behavioral and post-acute sequelae of SARS-CoV-2 infection.
Original language | English (US) |
---|---|
Title of host publication | Frontiers of COVID-19 |
Subtitle of host publication | Scientific and Clinical Aspects of the Novel Coronavirus 2019 |
Publisher | Springer International Publishing |
Pages | 241-257 |
Number of pages | 17 |
ISBN (Electronic) | 9783031080456 |
ISBN (Print) | 9783031080449 |
DOIs | |
State | Published - Jan 1 2022 |
All Science Journal Classification (ASJC) codes
- Medicine(all)